Lippman SM - Search Results

1

Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II, Koo JS. Seo HS, et al. Among authors: lippman sm. Cancer Res. 2008 Aug 1;68(15):6065-73. doi: 10.1158/0008-5472.CAN-07-5376. Cancer Res. 2008. PMID: 18676828 Free PMC article.

2

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: lippman sm. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

3

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. Heyne KH, et al. Among authors: lippman sm. J Clin Oncol. 1992 Oct;10(10):1519-24. doi: 10.1200/JCO.1992.10.10.1519. J Clin Oncol. 1992. PMID: 1328547

4

Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.

Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK. Benner SE, et al. Among authors: lippman sm. Int J Cancer. 1992 Aug 19;52(1):44-7. doi: 10.1002/ijc.2910520110. Int J Cancer. 1992. PMID: 1500226

5

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: lippman sm. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

6

Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium.

Lippman SM, Peters EJ, Wargovich MJ, Stadnyk AN, Dixon DO, Dekmezian RH, Loewy JW, Morice RC, Cunningham JE, Hong WK. Lippman SM, et al. Int J Cancer. 1990 May 15;45(5):811-5. doi: 10.1002/ijc.2910450503. Int J Cancer. 1990. PMID: 2335384

7

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Xu XC, et al. Among authors: lippman sm. Cancer Res. 1995 Dec 1;55(23):5507-11. Cancer Res. 1995. PMID: 7585623

8

Chemoprevention of lung cancer.

Benner SE, Lippman SM, Hong WK. Benner SE, et al. Among authors: lippman sm. Chest. 1995 Jun;107(6 Suppl):316S-321S. doi: 10.1378/chest.107.6_supplement.316s. Chest. 1995. PMID: 7781413 Review.

9

p53 and retinoid chemoprevention of oral carcinogenesis.

Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. Lippman SM, et al. Cancer Res. 1995 Jan 1;55(1):16-9. Cancer Res. 1995. PMID: 7805028 Clinical Trial.

10

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B, et al. Fossella FV, et al. J Clin Oncol. 1995 Mar;13(3):645-51. doi: 10.1200/JCO.1995.13.3.645. J Clin Oncol. 1995. PMID: 7884425 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters